[{"command":"openDialog","selector":"#drupal-modal","settings":null,"data":"\u003Cdiv id=\u0022republish_modal_form\u0022\u003E\u003Cform class=\u0022modal-form-example-modal-form ecl-form\u0022 data-drupal-selector=\u0022modal-form-example-modal-form\u0022 action=\u0022\/en\/article\/modal\/12404\u0022 method=\u0022post\u0022 id=\u0022modal-form-example-modal-form\u0022 accept-charset=\u0022UTF-8\u0022\u003E\u003Cp\u003EHorizon articles can be republished for free under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence.\u003C\/p\u003E\n \u003Cp\u003EYou must give appropriate credit. We ask you to do this by:\u003Cbr \/\u003E\n 1) Using the original journalist\u0027s byline\u003Cbr \/\u003E\n 2) Linking back to our original story\u003Cbr \/\u003E\n 3) Using the following text in the footer: This article was originally published in \u003Ca href=\u0027#\u0027\u003EHorizon, the EU Research and Innovation magazine\u003C\/a\u003E\u003C\/p\u003E\n \u003Cp\u003ESee our full republication guidelines \u003Ca href=\u0027\/horizon-magazine\/republish-our-stories\u0027\u003Ehere\u003C\/a\u003E\u003C\/p\u003E\n \u003Cp\u003EHTML for this article, including the attribution and page view counter, is below:\u003C\/p\u003E\u003Cdiv class=\u0022js-form-item form-item js-form-type-textarea form-item-body-content js-form-item-body-content ecl-form-group ecl-form-group--text-area form-no-label ecl-u-mv-m\u0022\u003E\n \n\u003Cdiv\u003E\n \u003Ctextarea data-drupal-selector=\u0022edit-body-content\u0022 aria-describedby=\u0022edit-body-content--description\u0022 id=\u0022edit-body-content\u0022 name=\u0022body_content\u0022 rows=\u00225\u0022 cols=\u002260\u0022 class=\u0022form-textarea ecl-text-area\u0022\u003E\u003Ch2\u003E3D-printed living cells pave way for tomorrow\u0027s medicine and cruelty-free animal products\u003C\/h2\u003E\u003Cp\u003E3D printing has come a long way since its early days in the 1980s and is considered an essential tool in many manufacturing processes. Now, however, researchers like Italian bioengineer Dr Riccardo Levato, are taking the technique in a new and exciting direction.\u003C\/p\u003E\u003Cp\u003EWhat if, as well as car parts and designer furniture, we could print human organs or regenerate human tissue by bioprinting living cells?\u003C\/p\u003E\u003Cp\u003ELevato,\u0026nbsp;an associate professor of biofabrication and regenerative medicine at the University Medical Center Utrecht and at Utrecht University, the Netherlands, leads a team of researchers from Belgium, Italy, the Netherlands, Sweden and Switzerland who received EU funding to do just that.\u003C\/p\u003E\u003Cp\u003EAs part of a research initiative called\u0026nbsp;\u003Ca href=\u0022https:\/\/cordis.europa.eu\/project\/id\/964497\u0022\u003EENLIGHT\u003C\/a\u003E which runs from 2021 to 2025, they are developing a miniature 3D-printed pancreas made of human cells.\u0026nbsp;\u003C\/p\u003E\u003Cp\u003EThis, they hope, could improve the reliability and accuracy of testing of new therapies to treat diabetes and, perhaps, even one day lead to the possibility of lab-grown organs for human transplants.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003ELiving blueprint\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003EOne of the key working materials of this research is stem cells. These are cells that have the potential to grow into many different types of human tissue \u2013\u0026nbsp;muscle cells, blood cells, brain cells \u2013 depending on the signals they receive.\u003C\/p\u003E\u003Cp\u003EInitial experiments, aimed at supporting patients with diabetes, have been carried out using insulin-producing cells grown in a lab from stem cells. Simply transplanting these cells into an ailing pancreas provides only short-term relief, however. According to Levato, this is because the cells lack proper support.\u003C\/p\u003E\u003Cp\u003E\u003Cblockquote class=\u0022tw-text-center tw-text-blue tw-font-bold tw-text-2xl lg:tw-w-1\/2 tw-border-2 tw-border-blue tw-p-12 tw-my-8 lg:tw-m-12 lg:tw--ml-16 tw-float-left\u0022\u003E\n \u003Cspan class=\u0022tw-text-5xl tw-rotate-180\u0022\u003E\u201c\u003C\/span\u003E\n \u003Cp class=\u0022tw-font-serif tw-italic\u0022\u003EWe essentially create a sort of light hologram of the object we want to print.\u003C\/p\u003E\n \u003Cfooter\u003E\n \u003Ccite class=\u0022tw-not-italic tw-font-normal tw-text-sm tw-text-black\u0022\u003ERiccardo Levato, ENLIGHT\u003C\/cite\u003E\n \u003C\/footer\u003E\n\u003C\/blockquote\u003E\n\u003C\/p\u003E\u003Cp\u003E\u2018When you deliver these cells without structure, without vasculature, without protective material around them, they will die over time,\u2019 he said. \u2018The procedure lasts only a few years and then you have to repeat it.\u2019\u003C\/p\u003E\u003Cp\u003ELevato and the ENLIGHT team are trying to fix this by 3D printing human tissue, living cells, to form three-dimensional implants complete with vessels. This is challenging because living cells are fragile and will not survive a normal 3D printing process.\u003C\/p\u003E\u003Cp\u003EThe researchers have tackled this by using water-rich gels, called bioinks, that carry and nurture the cells during the printing process. They then need to be able to guide the process of cell differentiation so that the organ develops in line with its genetic \u201cblueprint\u201d. They do this using light.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003ELight touch\u0026nbsp;\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003EThe ENLIGHT researchers have developed a novel 3D printing technique that uses light to shape the cell-containing bioink, instead of squeezing it through a nozzle like in a conventional 3D printer, which would damage the cells.\u003C\/p\u003E\u003Cp\u003E\u2018We essentially create a sort of light hologram of the object we want to print in the middle of this medium,\u2019 Levato said.\u0026nbsp;\u003C\/p\u003E\u003Cp\u003E\u2018Where you have this 3D light structure, the medium becomes solid and everywhere else it remains liquid so you can just wash it out. The cells are entrapped in the gelatine-like form, which is similar to the extra-cellular matrix in a living tissue.\u2019\u003C\/p\u003E\u003Cp\u003EThe researchers then nudge the cells to mature into insulin-producing cells by exposing them to light of specific wavelengths.\u0026nbsp;\u003C\/p\u003E\u003Cp\u003EThe team is currently testing their implants in the laboratory and researchers hope such 3D printed organoids can become part of standard drug development procedures before the end of the decade.\u0026nbsp;\u003C\/p\u003E\u003Cp\u003ELevato cautioned, however, that it would take quite a bit longer to make the bioprinted organoids suitable for transplantation into human patients.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003ECruelty-free\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003EOne of the advantages of the ENLIGHT team\u2019s work is that it could greatly reduce the need for animal testing. Being able to print life-like human organoids would not only improve the accuracy of drug testing, but would mean that the suffering of millions of laboratory animals could be avoided.\u0026nbsp;\u003C\/p\u003E\u003Cp\u003EDr Massimo Vassalli, a professor of bioengineering\u0026nbsp;at the University of Glasgow in the UK, is taking the concept of 3D printing of living tissue in a slightly different direction, but one that could also potentially relieve animal suffering.\u0026nbsp;\u003C\/p\u003E\u003Cp\u003EHe leads a multi-country EU-funded research initiative called\u0026nbsp;\u003Ca href=\u0022https:\/\/cordis.europa.eu\/project\/id\/101070913\u0022\u003EPRISM-LT\u003C\/a\u003E which aims to develop cost-effective 3D printing of a variety of living tissues. Their work, which will run until 2027, could have relevant applications in both\u0026nbsp;biomedicine and food production.\u003C\/p\u003E\u003Cp\u003E\u003Cblockquote class=\u0022tw-text-center tw-text-blue tw-font-bold tw-text-2xl lg:tw-w-1\/2 tw-border-2 tw-border-blue tw-p-12 tw-my-8 lg:tw-m-12 lg:tw--ml-16 tw-float-left\u0022\u003E\n \u003Cspan class=\u0022tw-text-5xl tw-rotate-180\u0022\u003E\u201c\u003C\/span\u003E\n \u003Cp class=\u0022tw-font-serif tw-italic\u0022\u003EWe see a big role for 3D bioprinting in sustainable and clean food production.\u003C\/p\u003E\n \u003Cfooter\u003E\n \u003Ccite class=\u0022tw-not-italic tw-font-normal tw-text-sm tw-text-black\u0022\u003EMassimo Vassalli, PRISM-LT\u003C\/cite\u003E\n \u003C\/footer\u003E\n\u003C\/blockquote\u003E\n\u003C\/p\u003E\u003Cp\u003E\u2018The aim of the project is to create a platform technology to address the manufacturing of a diverse range of living tissues for application in the healthcare and food industries,\u2019 said Vassalli. \u2018In fact, beyond the more obvious medical uses, we see a big role for 3D bioprinting in sustainable and clean food production,\u2019 he said.\u003C\/p\u003E\u003Cp\u003EThe challenge, according to Vassalli, is to create complex heterogeneous tissues that truthfully mimic the texture of living materials. For example, meat contains muscle cells and fat cells, but also cells that form the connective tissues.\u0026nbsp;\u003C\/p\u003E\u003Cp\u003ETo create meat that feels like the real thing, the researchers need to find ways to instruct stem cells to produce exactly the required type of tissue within a pre-defined structure \u2013 and then sustain the process over time.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003ERefining differentiation\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003EThe researchers are exploring an approach that mimics symbiotic processes in nature. They are mixing bacteria or yeasts \u2013 which Vassalli calls worker or helper cells \u2013 with the stem cells in a 3D printing bioink to help guide the differentiation process.\u0026nbsp;\u003C\/p\u003E\u003Cp\u003E\u2018These cells are either bacteria or yeast that can sense the direction in which the cells are going and start producing chemicals to help them differentiate further,\u2019 he said.\u003C\/p\u003E\u003Cp\u003EThe team expect to be able to create centimetre-scale tissue cubes by the end of the project, focusing first on 3D-printed bone marrow for medical applications and a sample of marbled cultured meat.\u0026nbsp;\u003C\/p\u003E\u003Cp\u003E\u2018Bioprinting technology offers improved flexibility in the design of the final composition of the tissue. This meets the needs of personalised healthcare applications,\u2019 said Vassalli.\u003C\/p\u003E\u003Cp\u003E\u2018Food will take longer because the scale-up of the technology will take a lot of energy. A 3D printer we use in a lab wouldn\u2019t be suitable to produce meat for a population. There is a technological gap that needs to be closed.\u2019\u003C\/p\u003E\u003Cp\u003E\u003Cem\u003EResearch in this article was funded by the European Innovation Council (EIC). The views of the interviewees don\u2019t necessarily reflect those of the European Commission. If you liked this article, please consider sharing it on social media.\u003C\/em\u003E\u003C\/p\u003E\u003C\/textarea\u003E\n\u003C\/div\u003E\n\n \u003Cdiv id=\u0022edit-body-content--description\u0022 class=\u0022ecl-help-block description\u0022\u003E\n Please copy the above code and embed it onto your website to republish.\n \u003C\/div\u003E\n \u003C\/div\u003E\n\u003Cinput autocomplete=\u0022off\u0022 data-drupal-selector=\u0022form-xojpsqxdkpfzlvxgk3tddufhfjsvmlffuahicvvlq-a\u0022 type=\u0022hidden\u0022 name=\u0022form_build_id\u0022 value=\u0022form-xoJPSqxdKpFZLVxGk3TddUFhfJSVMlFFuaHiCVVlQ_A\u0022 \/\u003E\n\u003Cinput data-drupal-selector=\u0022edit-modal-form-example-modal-form\u0022 type=\u0022hidden\u0022 name=\u0022form_id\u0022 value=\u0022modal_form_example_modal_form\u0022 \/\u003E\n\u003C\/form\u003E\n\u003C\/div\u003E","dialogOptions":{"width":"800","modal":true,"title":"Republish this content"}}]